These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12406535)

  • 1. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
    Turton S; Myers JF; Mick I; Colasanti A; Venkataraman A; Durant C; Waldman A; Brailsford A; Parkin MC; Dawe G; Rabiner EA; Gunn RN; Lightman SL; Nutt DJ; Lingford-Hughes A
    Mol Psychiatry; 2020 Aug; 25(8):1749-1758. PubMed ID: 29942043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: a pilot study.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; Deboer MD; Maslowski EC; Monteiro AA; Vincent MB; Zubieta JK; DaSilva AF
    Mol Pain; 2012 Sep; 8():74. PubMed ID: 23006894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social Laughter Triggers Endogenous Opioid Release in Humans.
    Manninen S; Tuominen L; Dunbar RI; Karjalainen T; Hirvonen J; Arponen E; Hari R; Jääskeläinen IP; Sams M; Nummenmaa L
    J Neurosci; 2017 Jun; 37(25):6125-6131. PubMed ID: 28536272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mu-Opioid receptors and limbic responses to aversive emotional stimuli.
    Liberzon I; Zubieta JK; Fig LM; Phan KL; Koeppe RA; Taylor SF
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7084-9. PubMed ID: 12011464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking.
    Ellis CR; Kruhlak NL; Kim MT; Hawkins EG; Stavitskaya L
    PLoS One; 2018; 13(5):e0197734. PubMed ID: 29795628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache.
    DaSilva AF; Nascimento TD; Love T; DosSantos MF; Martikainen IK; Cummiford CM; DeBoer M; Lucas SR; Bender MA; Koeppe RA; Hall T; Petty S; Maslowski E; Smith YR; Zubieta JK
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24962460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expectancy Modulation of Opioid Neurotransmission.
    Pecina M; Zubieta JK
    Int Rev Neurobiol; 2018; 138():17-37. PubMed ID: 29681324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain imaging in the emerging era of molecular medicine.
    Stohler CS; Zubieta JK
    Methods Mol Biol; 2010; 617():517-37. PubMed ID: 20336446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
    Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
    Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioid systems alterations in pain and opioid use disorder.
    Higginbotham JA; Markovic T; Massaly N; Morón JA
    Front Syst Neurosci; 2022; 16():1014768. PubMed ID: 36341476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A candidate neuroimaging biomarker for detection of neurotransmission-related functional alterations and prediction of pharmacological analgesic response in chronic pain.
    Martins D; Veronese M; Turkheimer FE; Howard MA; Williams SCR; Dipasquale O
    Brain Commun; 2022; 4(1):fcab302. PubMed ID: 35169702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Survey of Molecular Imaging of Opioid Receptors.
    Cumming P; Marton J; Lilius TO; Olberg DE; Rominger A
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
    Colom M; Vidal B; Zimmer L
    Front Mol Neurosci; 2019; 12():255. PubMed ID: 31680859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging of endogenous mu-opioid mechanisms during pain and migraine.
    DaSilva AF; Zubieta JK; DosSantos MF
    Pain Rep; 2019; 4(4):e769. PubMed ID: 31579860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic Differences in the Effects of Naloxone on Sustained Evoked Pain: A Preliminary Study.
    Burton EF; Suen SY; Walker JL; Bruehl S; Peterlin BL; Tompkins DA; Buenaver LF; Edwards RR; Campbell CM
    Divers Equal Health Care; 2017; 14(5):236-242. PubMed ID: 30984393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain catastrophizing may moderate the association between pain and secondary hyperalgesia.
    Pressman AJ; Peterlin BL; Tompkins DA; Salas RE; Buenaver LF; Haythornthwaite JA; Campbell CM
    J Appl Biobehav Res; 2017 Mar; 22(1):. PubMed ID: 30983846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat.
    Thompson SJ; Pitcher MH; Stone LS; Tarum F; Niu G; Chen X; Kiesewetter DO; Schweinhardt P; Bushnell MC
    Pain; 2018 Sep; 159(9):1856-1866. PubMed ID: 29794614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid system and human emotions.
    Nummenmaa L; Tuominen L
    Br J Pharmacol; 2018 Jul; 175(14):2737-2749. PubMed ID: 28394427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.